Drugnews|藥時事

LLF-KY

羅麗芬控股股份有限公司

6666 · TWSE-listed

LLF-KY focuses on skincare research and development, brands and distribution, as of 2026-11-01.

Pipeline and products

No publicly disclosed new-drug pipeline.

Key events

No public update recorded for this period.

Related Drugnews articles

No related articles in this language.